ATC
ABBV icon

Argent Trust Co’s AbbVie ABBV Stock Holding History

Argent Trust Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43M Sell
197,784
-98
-0% -$21.7K 1.46% 10
2025
Q4 		$45.2M Sell
197,882
-7,163
-3% -$1.63M 1.55% 9
2025
Q3 		$47.5M Sell
205,045
-3,119
-1% -$635K 1.68% 8
2025
Q2 		$38.6M Buy
208,164
+6,705
+3% +$1.25M 1.46% 10
2025
Q1 		$42.2M Buy
201,459
+1,033
+0.5% +$201K 1.73% 5
2024
Q4 		$35.6M Buy
200,426
+540
+0.3% +$99.3K 1.45% 10
2024
Q3 		$39.5M Sell
199,886
-4,286
-2% -$800K 1.63% 9
2024
Q2 		$35M Buy
204,172
+1,882
+0.9% +$312K 1.54% 8
2024
Q1 		$36.8M Buy
202,290
+3,233
+2% +$557K 1.66% 7
2023
Q4 		$30.8M Buy
199,057
+2,149
+1% +$313K 1.53% 8
2023
Q3 		$29.4M Buy
196,908
+722
+0.4% +$106K 1.61% 7
2023
Q2 		$26.4M Buy
196,186
+11,661
+6% +$1.71M 1.43% 10
2023
Q1 		$29.4M Buy
184,525
+4,747
+3% +$726K 1.86% 5
2022
Q4 		$29.1M Sell
179,778
-864
-0.5% -$132K 1.92% 7
2022
Q3 		$24.2M Buy
180,642
+4,339
+2% +$623K 1.75% 6
2022
Q2 		$27M Buy
176,303
+647
+0.4% +$98.9K 1.85% 6
2022
Q1 		$28.5M Sell
175,656
-817
-0.5% -$119K 1.74% 6
2021
Q4 		$23.9M Buy
176,473
+1,267
+0.7% +$150K 1.4% 10
2021
Q3 		$18.9M Buy
175,206
+5,539
+3% +$633K 1.21% 13
2021
Q2 		$19.1M Buy
169,667
+29,182
+21% +$3.29M 1.25% 13
2021
Q1 		$15.2M Buy
140,485
+5,127
+4% +$548K 1.07% 22
2020
Q4 		$14.5M Buy
135,358
+3,811
+3% +$366K 1.12% 19
2020
Q3 		$11.5M Buy
131,547
+3,583
+3% +$337K 1.02% 26
2020
Q2 		$12.6M Buy
127,964
+14,700
+13% +$1.29M 1.18% 16
2020
Q1 		$8.63M Sell
113,264
-2,708
-2% -$231K 0.97% 32
2019
Q4 		$10.3M Buy
115,972
+1,478
+1% +$123K 0.91% 31
2019
Q3 		$8.67M Buy
114,494
+4,772
+4% +$327K 0.84% 35
2019
Q2 		$7.98M Buy
109,722
+1,094
+1% +$86K 0.81% 33
2019
Q1 		$8.76M Buy
108,628
+3,203
+3% +$262K 0.92% 29
2018
Q4 		$9.72M Buy
105,425
+4,682
+5% +$412K 1.14% 20
2018
Q3 		$9.46M Buy
100,743
+5,484
+6% +$520K 1.09% 17
2018
Q2 		$8.82M Buy
95,259
+54,064
+131% +$5.28M 1.08% 19
2018
Q1 		$3.9M Buy
41,195
+24,302
+144% +$2.67M 1.12% 20
2017
Q4 		$1.63M Sell
16,893
-11,472
-40% -$1.08M 0.64% 45
2017
Q3 		$2.52M Buy
28,365
+1,487
+6% +$113K 0.99% 19
2017
Q2 		$1.95M Sell
26,878
-1,043
-4% -$70.1K 0.8% 31
2017
Q1 		$1.82M Sell
27,921
-1,414
-5% -$88.9K 0.75% 33
2016
Q4 		$1.84M Sell
29,335
-984
-3% -$60.1K 0.81% 31
2016
Q3 		$1.91M Sell
30,319
-3,656
-11% -$237K 0.81% 27
2016
Q2 		$2.1M Sell
33,975
-1,278
-4% -$77.9K 0.93% 23
2016
Q1 		$2.01M Buy
+35,253
New +$1.96M 0.98% 22
2015
Q4 		– Sell
-18,174
Closed -$989K – 228
2015
Q3 		$989K Buy
18,174
+91
+0.5% +$5.92K 0.56% 57
2015
Q2 		$1.22M Sell
18,083
-1,544
-8% -$101K 0.61% 47
2015
Q1 		$1.15M Buy
19,627
+1,939
+11% +$117K 0.58% 54
2014
Q4 		$1.16M Buy
+17,688
New +$1.12M 0.7% 39

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argent Trust Co's ABBV Position: Q1 2026 in Review

Argent Trust Co reduced its AbbVie (ABBV) stake by 0.05% in Q1 2026, selling an estimated $21.7K and leaving 197,784 shares worth $43M. The position accounts for 1.46% of the portfolio, ranked #10.

Argent Trust Co first reported a position in ABBV in Q4 2014 and has held it in 45 quarters since. The position peaked at $47.5M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Argent Trust Co held 197,784 shares of AbbVie worth $43M as of Q1 2026.
  • Argent Trust Co sold 98 AbbVie shares in Q1 2026, an estimated $21.7K.
  • AbbVie made up 1.46% of Argent Trust Co's portfolio in Q1 2026, its #10 holding.
  • Argent Trust Co first reported a position in AbbVie in Q4 2014 and has held it in 45 quarters since.
  • Argent Trust Co's AbbVie position peaked at $47.5M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.